Velaglucerase alfa
Vpriv (velaglucerase alfa) is an enzyme pharmaceutical. Velaglucerase alfa was first approved as Vpriv on 2010-02-26. It is used to treat gaucher disease in the USA. It has been approved in Europe to treat gaucher disease.
| Trade Name | Vpriv |
|---|---|
| Common Name | Velaglucerase alfa |
| Indication | gaucher disease |
| Drug Class | Enzymes |
